TRIESTE, LEOPOLDO
 Distribuzione geografica
Continente #
EU - Europa 226
NA - Nord America 206
AS - Asia 70
AF - Africa 39
OC - Oceania 1
SA - Sud America 1
Totale 543
Nazione #
US - Stati Uniti d'America 203
IT - Italia 84
SE - Svezia 65
IN - India 25
SG - Singapore 25
GB - Regno Unito 23
CI - Costa d'Avorio 21
BG - Bulgaria 19
DE - Germania 14
SN - Senegal 9
NG - Nigeria 8
FR - Francia 6
CN - Cina 5
ID - Indonesia 5
HK - Hong Kong 4
CZ - Repubblica Ceca 3
JP - Giappone 3
PL - Polonia 3
CA - Canada 2
CH - Svizzera 2
ES - Italia 2
VN - Vietnam 2
AU - Australia 1
BR - Brasile 1
EE - Estonia 1
EG - Egitto 1
IE - Irlanda 1
LV - Lettonia 1
MX - Messico 1
SI - Slovenia 1
TH - Thailandia 1
UA - Ucraina 1
Totale 543
Città #
Chandler 29
Serra 27
Ashburn 25
Abidjan 21
Florence 19
Sofia 19
London 17
New York 17
Fairfield 12
Princeton 11
Redwood City 11
Dakar 9
Lagos 8
Lawrence 8
Marseille 6
Medford 6
Rome 6
Singapore 6
Wilmington 6
Dallas 5
Hyderabad 5
Jakarta 5
Pisa 5
Duncan 4
Hong Kong 4
Milan 4
Scarlino 4
Washington 4
Ann Arbor 3
Bengaluru 3
Bremen 3
Esslingen am Neckar 3
Houston 3
Kent 3
Mumbai 3
Ogden 3
Redmond 3
San Diego 3
Warsaw 3
Brno 2
Chicago 2
Füllinsdorf 2
Madrid 2
Naples 2
Toronto 2
Bacoli 1
Belfast 1
Bhubaneswar 1
Boardman 1
Cairo 1
Cambridge 1
Cogorno 1
Doncaster 1
Dublin 1
Frascati 1
Genova 1
Ljubljana 1
Lucca 1
Monza 1
Norwalk 1
Olomouc 1
Padova 1
Pontotoc 1
Porto Azzurro 1
San Francisco 1
Tacoma 1
Tallinn 1
Tokyo 1
Totale 371
Nome #
Validation test for algorithms to identify rheumatoid arthritis patients in the Tuscan healthcare administrative databases 84
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons 80
Longitudinal adherence trajectories to biologic disease modifying anti-rheumatic drugs in Tuscany, Italy 73
Trajectories of use of biologic disease modifying antirheumatic drugs in rheumatoid arthritis: A cohort study of Tuscan patients, Italy 65
Recommendations by the Tuscan Health Authority to Use Infliximab-Biosimilar in the Clinical Practice: Safety Impact 52
Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases 52
Trajectories of Adherence to Biologic Disease-Modifying Anti-Rheumatic Drugs in Tuscan Administrative Databases: The Pathfinder Study 52
The Economic Impact of the Introduction of Infliximab-Biosimilar: Preliminary Results from a Study on Rheumatologic Patients in Tuscany, Italy 48
Switching from infliximab-originator to infliximab-biosimilar in rheumatologic patients: The clinical impact in Tuscan Region, Italy 45
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy 10
Totale 561
Categoria #
all - tutte 2.816
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.816


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202136 0 0 0 1 3 0 7 3 5 0 2 15
2021/2022177 6 8 23 35 25 14 9 8 5 4 13 27
2022/2023200 27 40 18 6 14 15 8 4 45 0 23 0
2023/2024143 0 10 15 2 14 30 19 18 0 0 13 22
2024/20255 5 0 0 0 0 0 0 0 0 0 0 0
Totale 561